Clinical Trial Update: A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the efficacy and safety of adding all-trans retinoic acid to the VAC chemotherapy regimen for intermediate-to-high-risk rhabdo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Actinomycin D (dactinomycin)
• All-trans Retinoic Acid (all-trans retinoic acid)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Rhabdomyosarcoma | Phase 2 | Status: NOT_YET_RECRUITING